Emphasizing foreign origins of a disease can have racist connotations and implications for how people understand their own risk of disease.
Rigor acadêmico, estilo jornalístico
Todos os artigos de Infectious diseases
Exibindo 221 - 240 de 495 artigos
Today’s coronavirus pandemic has echoes in the yellow fever pandemic of the 1790s. Then, as now, workers struggled with how to support themselves and their families. One federal agency had the answer.
The COVID-19 pandemic must be managed in India in a tense economic context and with a largely privatised health system.
How do you know what you’re reading and hearing about COVID-19 is based on fact not myth? Here are the basics, and we’ve created an at-a-glance infographic to make it easier to digest.
Why 1.5 metres? Is it our best estimate or is there solid evidence behind it?
Aboriginal people are at greater risk of severe illness from COVID-19 than non-Aboriginal people. But plans to protect remote communities and keep the virus out are progressing too slowly.
The SARS-CoV-2 virus responsible for the COVID-19 pandemic is undergoing extensive genetic analysis around the world to understand its origin and evolution.
There’s no shortage of myths, scams and spurious claims circulating about coronavirus.
The face mask shortage shows how governments can either work together with global supply chains in positive ways or revert to state-centric policies that prevent us from dealing with COVID-19.
As response to COVID-19 moves from a learning phase to an operational phase, lessons from the 2009 H1N1 pandemic can inform Canada’s action plan.
It took decades for scientists to recognize HIV/AIDS as a new disease, and years longer to mobilize an effective response with broad public support. Will the US do better against novel coronavirus?
Non-essential mass gatherings of 500 people or more are banned from today. Here’s why that’s a good idea.
As the new coronavirus has spread around the world, sporting matches and events have been staged behind closed doors, postponed and increasingly cancelled outright.
Many homeless people already have compromised immune systems. They are targets – and conduits – for COVID-19.
Not everyone who wants a telehealth consultation with their doctor over the next six months will be eligible for one.
How do we develop new drugs quickly yet safely? How prepared are we to give up some personal freedoms? And how do we allocate scarce resources? These are just some of the tough questions we face.
Don’t count on it, says virologist.
Health-care workers are our most valuable asset in an outbreak. We must protect them as best we can.
There are many questions left unanswered because the outbreak is still in an early stage.
An effective vaccine against lies, spin and confusion.
Principais colaboradores
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Infectious Diseases, Monash University
-
Associate Professor, Epidemiology, Deakin University
-
Adjunct Associate Professor, Faculty of Medicine, The University of Queensland
-
Associate Professor and Epidemiologist, Infectious Diseases, Immunisation and Emergencies Group, Sydney School of Public Health, University of Sydney
-
Associate Professor of Medicine, Infectious Diseases Physician, Australian National University
-
Virologist, The University of Queensland
-
John Curtin Distinguished Professor of Health Science, Curtin University
-
Professor of Medicine, University of Virginia
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Deputy Director, WHO Collaborating Centre for Reference and Research on Influenza
-
Regents' Professor & Chair, Medical Laboratory Science, Texas State University
-
Infectious Diseases Physician, Senior Lecturer, James Cook University and, The University of Queensland
-
Hon Prof, Dept of Child & Adolescent Health, University of Sydney
-
Associate Principal Research Fellow, Burnet Institute
